SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: 5-YEAR DATA FROM TENDER, A PHASE 3 CLINICAL TRIAL

被引：1

作者：

De Benedetti, F. ^{[1
]}

Ruperto, N. ^{[2
]}

Brunner, H. ^{[3
]}

Keane, C. ^{[4
]}

Wells, C. ^{[4
]}

Wang, J. ^{[4
]}

Calvo, I. ^{[2
]}

Cuttica, R. ^{[2
]}

Ravelli, A. ^{[2
]}

Schneider, R. ^{[3
]}

Eleftheriou, D. ^{[2
]}

Wouters, C. ^{[2
]}

Xavier, R. ^{[2
]}

Zemel, L. ^{[3
]}

Baildam, E. ^{[2
]}

Burgos-Vargas, R. ^{[3
]}

Dolezalova, P. ^{[2
]}

Garay, S. M. ^{[2
]}

Joos, R. ^{[2
]}

Grom, A. ^{[3
]}

Wulffraat, N. ^{[2
]}

Zuber, Z. ^{[2
]}

Zulian, F. ^{[2
]}

Martini, A. ^{[2
]}

Lovell, D. ^{[3
]}

机构：

[1] IRCCS Osped Pediat Bambino Gesu, Rome, Italy

[2] Paediat Rheumatol Int Trials Org, Genoa, Italy

[3] Pediat Rheumatol Collaborat Study Grp, Cincinnati, OH USA

[4] Roche Prod Ltd, Welwyn Garden City, Herts, England

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷

关键词：

D O I：

10.1136/annrheumdis-2015-eular.3186

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

THU0508

引用

页码：384 / 384

页数：1

共 50 条

[1] 5-YEAR DATA FROM TENDER, A PHASE III CLINICAL TRIAL: SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
Baildam, Eileen
De Benedetti, Fabrizio
Ruperto, Nicola
Brunner, Hermine
Keane, Caroline
Wells, Chris
Wang, Jianmei
Calvo, Inmaculada
Cuttica, Ruben
Ravelli, Angello
Schneider, Rayfel
Eleftheriou, Despina
Wouters, Carine
Xavier, Ricardo
Zemel, Lawrence
Burgos-Vargas, Ruben
Dolezalova, Pavla
Garay, Stella M.
Joos, Rik
Grom, Alexei
Wulffraat, Nico
Zuber, Zbyszek
Zulian, Francesco
Martini, Alberto
Lovell, Daniel
[J]. RHEUMATOLOGY, 2016, 55 : 56 - 56
[2] EFFICACY AND SAFETY OF TOCILIZUMAB (TCZ) IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA): 2-YEAR DATA FROM TENDER, A PHASE 3 CLINICAL TRIAL
De Benedetti, F.
Brunner, H.
Ruperto, N.
Kenwright, A.
Devlin, C.
Calvo, I.
Cuttica, R.
Ravelli, A.
Schneider, R.
Eleftheriou, D.
Wouters, C.
Xavier, R.
Zemel, L.
Baildam, E.
Burgos-Vargas, R.
Dolezalova, P.
Garay, S. M.
Joos, R.
Grom, A.
Wulffraat, N.
Zuber, Z.
Zulian, F.
Lovell, D.
Martini, A.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 425 - 425
[3] Efficacy and safety of tocilizumab in patients with Systemic Juvenile Idiopathic Arthritis (sJIA): 12-week data from the Phase 3 TENDER trial
De Benedetti, F.
Brunner, H.
Ruperto, N.
Calvo, I.
Cutica, R.
Malattia, C.
Schneider, R.
Woo, P.
Wouters, C.
Xavier, R.
Zemel, L.
Wright, S.
Kenwright, A.
Lovell, D.
Martini, A.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 371 - 371
[4] Efficacy and Safety of Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis: 2-Year Data From a Phase III Clinical Trial
De Benedetti, Fabrizio
Brunner, Hermine
Ruperto, Nicolino
Kenwright, Andrew
Devlin, Clare
Calvo, Inmaculada
Cuttica, Ruben
Ravelli, Angelo
Schneider, Rayfel
Eleftheriou, Despina
Wouters, Carine H.
Xavier, Ricardo
Zemel, Lawrence S.
Baildam, Eileen M.
Burgos-Vargas, Ruben
Dolezalova, Pavla
Garay, Stella Maris
Joos, Rik
Grom, Alexei
Wulffraat, Nico
Zuber, Zbigniew
Zulian, Francesco
Martini, Alberto
Lovell, Daniel
[J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (12): : 4047 - 4047
[5] EFFICACY AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS: DATA FROM A PHASE 3 TRIAL
De Benedetti, F.
Ruperto, N.
Zuber, Z.
Keane, C.
Harari, O.
Kenwright, A.
Cuttica, R.
Keltsev, V.
Xavier, R.
Calvo, I.
Nikishina, I.
Rubio-Perez, N.
Alekseeva, E.
Chasnyk, V.
Chavez, J.
Horneff, G.
Opoka-Winiarska, V.
Quartier, P.
Silva, C.
Silverman, E.
Spindler, A.
Martini, A.
Lovell, D.
Brunner, H.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 70 - 70
[6] THE EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: 52-WEEK DATA FROM A PHASE 3 CLINICAL TRIAL
De Benedetti, Fabrizio
Brunner, Hermine
Allen, Roger
Brown, Diane
Chaitow, Jeffrey
Pardeo, Manuela
Espada, Graciela
Flato, Berit
Horneff, Gerd
Devlin, Clare
Kenwright, Andrew
Schneider, Rayfel
Woo, Patricia
Martini, Alberto
Lovell, Daniel
Ruperto, Nicola
[J]. RHEUMATOLOGY, 2012, 51 : 76 - 76
[7] Efficacy and Safety of Tocilizumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Data From a Phase 3 Trial.
Brunner, Hermine
Ruperto, Nicolino
Zuber, Zbigniew
Keane, Caroline
Harari, Olivier
Kenwright, Andrew
Cuttica, Ruben J.
Keltsev, Vladimir
Xavier, Ricardo
Penades, Inmaculada Calvo
Nikishina, Irina
Rubio-Perez, Nadina
Alekseeva, Ekaterina
Chasnyk, Vyacheslav
Chavez, Jose
Horneff, Gerd
Opoka-Winiarska, Violetta
Quartier, Pierre
Silva, Clovis A.
Silverman, Earl D.
Spindler, Alberto
Lovell, D. J.
Martini, Alberto
De Benedetti, Fabrizio
[J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S682 - S682
[8] Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data
F De Benedetti
H Brunner
N Ruperto
R Schneider
P Woo
R Burgos-Vargas
P Dolezalova
R Joos
N Wulffraat
Z Zuber
F Zulian
R Allen
D Brown
J Chaitow
M Pardeo
G Espada
B Flato
V Gerloni
G Horneff
S Wright
A Kenwright
D Lovell
A Martini
[J]. Pediatric Rheumatology, 9 (Suppl 1)
[9] Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data
Fabrizio De Benedetti
Hermine Brunner
Nicola Ruperto
R Cuttica
Clara Malattia
Rayfel Schneider
Patricia Woo
Despina Eleftheriou
Eileen Baildam
Ruben Burgos-Vargas
Pavla Dolezalova
Stella M Garay
Rik Joos
Nico Wulffraat
Zbyszek Zuber
Francesco Zulian
Carine Wouters
Ricardo M Xavier
Lawrence Zemel
Stephen Wright
Andy Kenwright
Alberto Martini
Daniel Lovell
[J]. Pediatric Rheumatology, 10 (Suppl 1)
[10] Efficacy and safety of tocilizumab in Chinese patients with systemic juvenile idiopathic arthritis: a multicentre phase IV trial
Li, Caifeng
Tang, Xuemei
Zhou, Zhixuan
Sun, Li
Lu, Meiping
Zhou, Wei
Yang, Sirui
Zheng, Wenjie
Yu, Haiguo
Tan, Weiping
Zhang, Junmei
Zhang, Yu
Kong, Yuxiu
Xu, Jiahui
[J]. CLINICAL RHEUMATOLOGY, 2024,

← 1 2 3 4 5 →